GLP-1 Agents May Reduce Psoriasis Severity - Quiz - MDSpire

GLP-1 Agents May Reduce Psoriasis Severity

National Psoriasis Foundation review highlights limited evidence and potential metabolic links.

  • By

  • Andrea Surnit

  • May 5, 2026

  • 4 min

Share

Original Source(s)

GLP-1 Agents May Reduce Psoriasis Severity

  • by Andrea Surnit

  • May 5, 2026

Related Content

Effectiveness, Safety, and Drug Survival of Bimekizumab in Chronic Plaque Psoriasis over 2 Years: Real-World Experience from Northern Italy

Rapid Onset of Action and Quality-of-Life Improvements in Chinese Patients with Plaque Psoriasis Treated with Calcipotriol plus Betamethasone Dipropionate Aerosol Foam in a Randomized Phase 3 Trial

Psoriasis as a systemic inflammatory disease: an immune set-point framework for comorbidities and relapse